Stop Bleeding Revenue. Start Collecting More.

Laboratory Billing Services

Is your lab overwhelmed by 12%+ denial rates? In 2025, the stakes are higher. With PAMA data collection mandates active and reimbursement cuts looming in 2026, you cannot afford “workflow chaos.”

We introduce AI-driven diagnostic laboratory billing solutions that don’t just “manage” bills they engineer profitability. We prepare your data for the 2026 CLFS reporting period today, ensuring your rates are protected tomorrow.

Lab Success? Don’t Guess.

Running a lab demands precision. Your billing should be no different.

If you continue to manage billing manually, you are likely losing 15-20% of your potential revenue to unappealed denials and write-offs.

Whether you run a High Complexity Molecular Lab or a Community Pathology Center, Dastify Solutions acts as your financial firewall. We perform predictive claim scrubbing before submission, ensuring your claims survive the strict edits of UnitedHealthcare, Anthem, and Medicare.

A++ RCM Solutions for the Modern Lab:

PAMA Data Collection: We automate the tracking of private payor rates now so you are ready for 2026 reporting.
AI-Driven Automation: Robotic Process Automation (RPA) for eligibility and prior auth.
Revenue Integrity Audits: Specialized for Global vs. Split (TC/PC) billing.
Interoperability: Seamless integration with 800+ LIS/EHR systems (Epic Beaker, Orchard, Sunquest).
No Surprises Act Compliance: Automated Good Faith Estimates (GFE) for self-pay patients.

What Makes Us Better Than Other Lab Billing Companies?

Years of Lab Billing Experience
100% HIPAA Compliance
3x Faster Payments
Certified Laboratory Billers & Coders (CPT, HCPCS Level II, ICD10)
98% Clean Claim Rate
50% Cut in your Overhead Burden
2x Reduced Denial Rate
9x Reduction in A/R
98% first-pass claims

Guaranteed Results for Your Laboratory

We Don't Just promise. We Benchmark. Industry Average Denial Rate: 11.8% (2024 Data). Our Rate: 4%.

Metric	Industry Standard	Dastify Performance
Collection Ratio	70–80%	93%+
Days in A/R	45–60 Days	30 Days or Less
Clean Claim Rate	85%	98.5% (First Pass)
Denial Rate	10–15%	4% (Lowest in Class)
Turnaround Time	30+ Days	7–14 Days
Revenue Impact	Stagnant	Up to 35% Increase

Laboratory Billing Services — Perfectly Customized

In-House & Reference Lab Billing

We handle billing for molecular pathology (NGS), toxicology, and microbiology, managing inter-lab reference agreements to prevent double-billing.

LIS Integration (HL7/FHIR)

We integrate directly with Epic Beaker, Cerner PathNet, Orchard, and Sunquest. This eliminates manual entry errors and ensures clinical data (like specimen collection dates) matches billing data.

Patient Eligibility & Pre-Auth

Real-time automated checks for frequency limits (e.g., Vitamin D, TSH). We flag "Medical Necessity" failures upfront so you can obtain an ABN (Advance Beneficiary Notice) before testing.

AI-driven Laboratory Billing Automation

At Dastify Solutions, you get highly certified coders who ensure 100% accuracy, compliance, and optimized reimbursements. Our AAPC-certified experts carefully handle and submit all claims.

Convenient Data Management

We bring all your billing data into one streamlined system by digitally filing claims, eliminating duplicates, and resolving conflicts before they slow you down.

ICD-10 & PAMA Compliance

Our ICD-10 experts make sure your claims are accurate and up-to-date. Moreover, we simplify PAMA compliance by managing your data collection and ensuring compliance.

Value-Based Services

We handle billing for value-based bundles, including genetic and molecular tests. And also help you in meeting the requirements for value-based services.

A/R Management

Our laboratory medical billing services reduce your days in A/R, improve your net collection rate, and minimize your charge lag. Also, increase your first-pass acceptance rate.

How Dastify Makes You the #1 Lab in the USA

We eliminate the errors that trigger audits.

When you choose us, we act as your compliance shield. We don't let your lab suffer from common, costly errors:

Wrong ICD-10 Coding: We ensure "Rule-Out" diagnoses are supported by specific clinical findings to meet LCD/NCD Medical Necessity criteria.
Missing Z-Codes: We mandate DEX Z-Code registration for molecular assays to prevent automatic rejections from Medicare Administrative Contractors (MACs).
MUE Edits: Our AI scrubbers flag claims that exceed Medically Unlikely Edits (MUE) like excessive toxicology units before they leave your system.
CLFS Pressure: We prepare you for the 2026 PAMA reporting period, ensuring your private payer data is collected accurately now to protect your future rates.

Automated Workflows. Less Manual Work.

Fast-paced labs need faster billing.

We bring AI-driven solutions that automate up to 60% of manual tasks:

NLP-Driven Coding: Computer-Assisted Coding (CAC) reads pathology reports to suggest accurate CPT codes.
Robotic Process Automation (RPA): Bots log into payer portals to verify eligibility and capture Prior Auth numbers instantly.
Claim Scrubbing: Every claim is checked against NCCI edits and duplicate testing rules to ensure it is "clean" before submission.

100% Compliance. Zero Surprises.

Your Financial Firewall Against Audits. As of December 2025, the regulatory landscape is shifting. We ensure your lab is fully prepared for the 2026 reporting cycles and new transparency laws.

PAMA 2026 Readiness: The next CLFS data reporting period begins January 1, 2026. We have already automated the collection of your private payer rates (from Jan–June 2025) to ensure you report accurately and avoid penalties.
No Surprises Act (NSA): We automate Good Faith Estimates (GFE) for self-pay patients at least 3 days prior to service, fully complying with transparency mandates.
MolDX Z-Code™ Management: We manage the registration of your molecular assays in the DEX Diagnostics Exchange to ensure your Z-Codes are active and linked to the correct CPTs for Medicare reimbursement.
Interoperability: Seamless HL7 integration with Epic, Cerner, and Sunquest ensures data integrity between your LIS and our billing engine.

Our Satisfied Clients

Dastify Solutions has been a huge help with all of our surgical prior authorizations. They are reliable, efficient, and make the process so much easier. We can always count on them, which allows us to focus on providing the best care for our patients. Highly recommend!

Dastify is awesome! They have assisted our company every step of the way. They are easy to work with and are always responsive and professional. I would recommend them for all of your billing needs!

Very happy with Dastify’s services for our practice. We highly recommend them! They are very thorough and professional.

FAQs.

How do you prepare our lab for PAMA 2026?

The PAMA data reporting period runs from Jan 1 – Mar 31, 2026. We have automated the tracking of your private payer rates and volumes from the 2025 collection period. We generate the required CMS reports for you, ensuring you meet the deadline without disrupting daily operations.

How do you handle complex molecular and genetic billing?

We specialize in MolDX compliance. We ensure your tests have valid DEX Z-Codes™ and are billed with the correct CPT codes and gene-specific modifiers. We also manage Prior Authorization (PA) for genetic panels to prevent backend denials.

Do you support Split Billing (TC/PC)?

Yes. We audit your claims to ensure the Technical Component (TC) and Professional Component (PC) are billed correctly based on where the test was performed and interpreted, preventing revenue leakage or double-billing compliance issues.

What is the cost of laboratory billing services?

We typically operate on a performance-based model (a small percentage of net collections). This aligns our incentives with yours—we only get paid when you get paid. Contact us for a specialized quote based on your test volume and complexity.

Need a Free Lab Billing Audit?

We are confident we can boost your collections. Don't let PAMA 2026 or Z-Code denials catch you off guard. Get a free audit of your current A/R and compliance status today.